SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-015980
Filing Date
2018-01-22
Accepted
2018-01-22 16:07:03
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d504802d424b4.htm 424B4 1737543
2 GRAPHIC g504802g03a96.jpg GRAPHIC 141602
3 GRAPHIC g504802g04e65.jpg GRAPHIC 135419
4 GRAPHIC g504802g07p99.jpg GRAPHIC 102312
5 GRAPHIC g504802g15c64.jpg GRAPHIC 44883
6 GRAPHIC g504802g21v14.jpg GRAPHIC 82516
7 GRAPHIC g504802g32j62.jpg GRAPHIC 150178
8 GRAPHIC g504802g50p86.jpg GRAPHIC 58551
9 GRAPHIC g504802g51j14.jpg GRAPHIC 45707
10 GRAPHIC g504802g53f75.jpg GRAPHIC 47389
11 GRAPHIC g504802g56i55.jpg GRAPHIC 21609
12 GRAPHIC g504802g59q99.jpg GRAPHIC 77151
13 GRAPHIC g504802g61v53.jpg GRAPHIC 44514
14 GRAPHIC g504802g64i82.jpg GRAPHIC 89730
15 GRAPHIC g504802g87e13.jpg GRAPHIC 44888
16 GRAPHIC g504802g94n34.jpg GRAPHIC 135891
  Complete submission text file 0001193125-18-015980.txt   3422276
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-222558 | Film No.: 18539946
SIC: 2834 Pharmaceutical Preparations